Guided Therapeutics (GTHP) Income from Continuing Operations (2010 - 2025)
Guided Therapeutics recorded quarterly Income from Continuing Operations of 1218000.0 in Q4 2025, down 64.15% quarter-over-quarter from 742000.0 in Q3 2025, and down 86.81% year-over-year from 9234139.53 in Q4 2024.
Guided Therapeutics' Income from Continuing Operations history runs 16 years deep, the most recent figure standing at 1218000.0 for Q4 2025.
- In Q4 2025, Income from Continuing Operations fell 86.81% year-over-year to 1218000.0; the TTM figure through Dec 2025 stood at 3198000.0 (down 32.31% YoY), while the FY2025 annual figure was 3196000.0, down 32.23% from the prior year.
- Income from Continuing Operations came in at 1218000.0 for Q4 2025 at Guided Therapeutics, down from 742000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 68000.0 in Q3 2021 to a low of 1807000.0 in Q4 2022.
- A 5-year average of 768650.0 and a median of 693000.0 in 2023 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations soared 84.68% in 2021 and sank 1720.59% in 2022, its largest moves.
- Guided Therapeutics' Income from Continuing Operations stood at 444000.0 in 2021, then sank by 306.98% to 1807000.0 in 2022, then soared by 78.64% to 386000.0 in 2023, then sank by 68.91% to 652000.0 in 2024, then tumbled by 86.81% to 1218000.0 in 2025.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 1218000.0, 742000.0, and 811000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | -1.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.22 Mn |
| Sep 30, 2025 | -742,000.00 |
| Jun 30, 2025 | -811,000.00 |
| Mar 31, 2025 | -427,000.00 |
| Dec 31, 2024 | -652,000.00 |
| Sep 30, 2024 | -654,000.00 |
| Jun 30, 2024 | -709,000.00 |
| Mar 31, 2024 | -402,000.00 |
| Dec 31, 2023 | -386,000.00 |
| Sep 30, 2023 | -677,000.00 |
| Jun 30, 2023 | -1.56 Mn |
| Mar 31, 2023 | -869,000.00 |
| Dec 31, 2022 | -1.81 Mn |
| Sep 30, 2022 | -1.10 Mn |
| Jun 30, 2022 | -926,000.00 |
| Mar 31, 2022 | -507,000.00 |
| Dec 31, 2021 | -444,000.00 |
| Sep 30, 2021 | 68,000.00 |
| Jun 30, 2021 | -1.03 Mn |
| Mar 31, 2021 | -517,000.00 |
| Dec 31, 2020 | 2.17 Mn |
| Sep 30, 2020 | 1.58 Mn |
| Jun 30, 2020 | -6.75 Mn |
| Mar 31, 2020 | 2.73 Mn |
| Dec 31, 2019 | 1.08 Mn |
| Sep 30, 2019 | -126,000.00 |
| Jun 30, 2019 | -2.66 Mn |
| Mar 31, 2019 | -215,000.00 |
| Dec 31, 2018 | -2.74 Mn |
| Sep 30, 2018 | -746,000.00 |
| Jun 30, 2018 | 3.42 Mn |
| Mar 31, 2018 | 1.08 Mn |
| Dec 31, 2017 | -8.74 Mn |
| Sep 30, 2017 | -2.37 Mn |
| Jun 30, 2017 | -1.07 Mn |
| Mar 31, 2017 | -107,000.00 |
| Dec 31, 2016 | -2.01 Mn |
| Sep 30, 2016 | -211,000.00 |
| Jun 30, 2016 | -1.88 Mn |
| Mar 31, 2016 | 130,000.00 |
| Dec 31, 2015 | -1.76 Mn |
| Sep 30, 2015 | -2.19 Mn |
| Jun 30, 2015 | -1.71 Mn |
| Mar 31, 2015 | -1.25 Mn |
| Dec 31, 2014 | 16.57 Mn |
| Sep 30, 2014 | -2.97 Mn |
| Jun 30, 2014 | -2.15 Mn |
| Mar 31, 2014 | 1.56 Mn |
| Dec 31, 2013 | 2.21 Mn |
| Sep 30, 2013 | 1.44 Mn |
| Jun 30, 2013 | 1.75 Mn |
| Mar 31, 2013 | 1.82 Mn |
| Dec 31, 2012 | 1.19 Mn |
| Sep 30, 2012 | 986,000.00 |
| Jun 30, 2012 | -1.17 Mn |
| Mar 31, 2012 | 1.01 Mn |
| Dec 31, 2011 | 2.76 Mn |
| Sep 30, 2011 | 2.66 Mn |
| Jun 30, 2011 | 496,000.00 |
| Mar 31, 2011 | 726,000.00 |
| Jun 30, 2010 | -503,000.00 |